-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Assumes Olema Pharmaceuticals at Buy, Lowers Price Target of $40

Benzinga·03/19/2026 19:43:57
Listen to the news
Jefferies analyst Dennis Ding assumes Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and lowers Price Target of $40.